Name: A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection (Video) | JoVE Journal
Uploaded: 2020-02-20T12:30:00.000+00:00
Duration: 6 min 56 s
Description: Learn a delayed inoculation protocol for chronic Pseudomonas aeruginosa wound infection in immunocompetent mice without immune suppression. This model enables bacterial pathogenesis and host-pathogen interaction studies.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The pUT-Tn5-EM7-lux-Km1 luminescent construct vector was a gracious gift from J. Hardy. Schematics were created with BioRender.com. We thank the lab of G. Gurtner for their advice on the wound infection model. We also thank T. Doyle from the Stanford Center for Innovation in In Vivo Imaging for his technical expertise. This work was supported by grants R21AI133370, R21AI133240, R01AI12492093, and grants from Stanford SPARK, the Falk Medical Research Trust and the Cystic Fibrosis Foundation (CFF) to P.L.B. C.R.D was supported by T32AI007502. A Gabilan Stanford Graduate Fellowship for Science and Engineering and a Lubert Stryer Bio-X Stanford Interdisciplinary Graduate Fellowship supported J.M.S.

All methods described here have been approved by the Institutional Animal Care and Use Committee (IACUC) at Stanford University.
1. Preparation and growth of bacteria
<ol>
	<li>Conduct all work with P. aeruginosa and animals with BSL-2 precautions per the researcher&#39;s institutional biosafety committee and animal use committee guidelines. Do all steps described here involving P. aeruginosa, including mouse inoculation, in a biosafety cabinet.</li>
	<li>The luminescent PAO1:lux strain of P. aeruginosa is available from our lab by request. Streak PAO1, stored as frozen glycerol stock, on Lysogeny Broth (LB) agar. For the luminescent PAO1:lux strain, LB agar should contain selective antibiotics (100 &#181;g/mL carbenicillin and 12.5 &#181;g/mL kanamycin). Grow at 37 &#176;C overnight in a bacterial incubator.</li>
	<li>Pick an isolated colony and grow overnight at 37 &#176;C in 3 ml LB medium, pH 7.4. For luminescent strains, broth should contain 100 &#181;g/mL carbenicillin. Grow under shaking, aerobic conditions.</li>
</ol>
2. Procedure preparation
<ol>
	<li>Have all personnel performing surgery wear a clean gown/Lab coat, face mask, hair net, and gloves.</li>
	<li>Autoclave all surgical tools, including scissors and forceps. Use aseptic technique to sterilize tools between animals.</li>
	<li>Clean the surgical table with ethanol and prepare a clean surgical field.</li>
</ol>
3. Hair removal
<ol>
	<li>Anesthetize 8&#8211;12 week old C57BL/6J mice using 1%&#8211;3% isoflurane. Investigators should follow their institution&#39;s veterinary staff guidelines for anesthesia when using isoflurane.
	<ol>
		<li>Start anesthesia by delivering 1%&#8211;3% isoflurane and adjust oxygen flow rate to 1.5 L/min. Place the mouse in the induction chamber.</li>
		<li>Pinch the mouse&#39;s toe to assess depth of anesthesia. When the mouse no longer responds to stimulation, remove it from the induction chamber and place it on the surgical bench with its nose in the isoflurane nose cone.</li>
		<li>Apply ocular lubricant to both eyes.</li>
	</ol>
	</li>
	<li>Weigh the mouse to obtain a baseline pre-procedure weight.</li>
	<li>Place the mouse in prone position. Inject the mouse subcutaneously with pre-warmed sterile 0.9% sodium chloride, 250 &#181;L at each flank for a total of 500 &#181;L.</li>
	<li>Shave the dorsal area of the mouse using an electric shaver. Shaving should occur at a different location than the surgical station to prevent hair contamination of the wound.</li>
	<li>Apply a thin layer of hair removal lotion. Let the lotion sit for 20&#8211;60 s. Remove the hair and excess lotion with gauze moistened in warm water. Following hair removal, proceed to the excisional wounding procedure.</li>
</ol>
4. Full thickness excisional wound surgery
<ol>
	<li>Inject sustained release buprenorphine 0.6&#8211;1 mg/kg subcutaneously using a 25 G needle at the mid-dorsal area of the mouse. Slow release buprenorphine provides pain relief over 48&#8211;72 h.</li>
	<li>Disinfect the surgical site. Wipe the dorsal surface with a sterile betadine swab. Wipe excess betadine with a sterile alcohol swab. This should be performed 3 times (alternating between betadine and alcohol), swabbing by moving from the center in a circular manner to the edge. Allow the area to air dry.</li>
	<li>Create a drape surrounding the surgical site using sterile gauze or plastic cling wrap.</li>
	<li>Stretch skin taut caudally. Use a sterile 6-mm diameter skin biopsy punch to make an initial incision through the left dorsal epidermis. Repeat on the right dorsal epidermis.</li>
	<li>Use forceps to tent the skin from the center of the left outlined wound area. Excise the epidermal and dermal layers using scissors. Repeat on the right outlined wound area to create symmetrical excisional wounds.</li>
	<li>Wash wounds with 50 &#181;L of sterile saline. Allow the surgical site and surrounding skin to air dry. Then, cover the wounds and dorsum with a transparent film dressing.</li>
	<li>Place the mouse back in a clean cage. House 1 animal per cage.</li>
	<li>Place the cage on a heating pad and monitor until the mouse wakes up.</li>
	<li>When performing the above surgery on multiple animals, use a hot bead sterilizer to clean all surgical instruments between animals.</li>
	<li>Allow 24 h for the mice to recover from the surgical procedure and for formation of a provisional wound matrix over the wounds prior to proceeding to inoculation with bacteria.</li>
</ol>
5. Inoculation with P. aeruginosa
<ol>
	<li>Dilute overnight PAO1:lux culture to OD600 = 0.05 in 75 mL of LB media containing 100 &#181;g/mL carbenicillin and grow the bacteria until the culture is in early exponential phase (OD600 &#8776; 0.3). This should take approximately 2&#8211;3 h.</li>
	<li>Dilute PAO1:lux in PBS to a concentration of (7.5 &#177; 2.5) x 102 CFU/mL. Be sure to prepare excess inoculum to ensure sufficient volume and to allow for plating after the experiment. If transporting between facilities (i.e. from the lab to the vivarium), use double containment in a leak proof box clearly marked Biohazard.</li>
	<li>Perform all work with P. aeruginosa and mice using approved personal protective equipment in an Animal Biosafety Level 2 (ABSL-2) approved biological safety cabinet (BSC). Reusable equipment such as the weighing scale should be covered with cling wrap to prevent contamination.</li>
	<li>Anesthetize using 3% isoflurane as described above. Weigh mouse and record the weight. Inject the mouse subcutaneously with pre-warmed sterile 0.9% sodium chloride, 250 &#181;L at each flank for a total of 500 &#181;L.</li>
	<li>If the mouse&#39;s transparent film dressing has come off overnight, remove any resulting scab carefully and put on a new dressing.</li>
	<li>Use a 500 &#181;L tuberculin 27 G safety cap syringe to inject 40 &#181;L of the PAO1:lux suspension through the transparent film dressing into each wound. Different mice should be used for non-inoculated/PBS wound controls in order to prevent cross-contamination from the contralateral side.</li>
	<li>Place the mouse back in its cage on a heating pad and monitor until it wakes up. All mice should be housed individually in separate cages to prevent cross-contamination.</li>
	<li>Provide high calorie nutritional supplement paste sandwiched between food pellets on the floor of the cage.</li>
	<li>Use the remaining inoculum to streak an LB agar plate. Count colonies to confirm the number of bacteria administered.</li>
</ol>
6. In vivo imaging of infected wounds
<ol>
	<li>Follow BSL-2 containment protocols for transport of mice to and from the imaging instrument, including use of a secondary container. Be careful not to transfer or drop any animal bedding during the transfer of the mouse to the induction chamber or imaging instrument.</li>
	<li>Induce anesthesia of the mouse with inhaled 1%&#8211;3% isoflurane in an induction chamber as described in step 3.1.</li>
	<li>Once the mouse is anesthetized, place it in prone position in the imaging chamber of an optical imaging system with the nose in the isoflurane nose cone.</li>
	<li>Open the software program.</li>
	<li>The acquisition parameters will vary based on the number of animals imaged simultaneously and intensity of bioluminescence. The basic parameters to set include exposure time, binning, f/stop, and field of view (FOV). Our default starting settings are exposure time 30 seconds, binning low (2), f/stop 1.2, and FOV 25. Adjust these settings as needed depending on the researcher&#39;s needs.</li>
	<li>Analyze luminescence data using an imaging program (see Table of Materials). Luminescence will be represented as a pseudocolor image overlaid on a color photograph of the mice.
	<ol>
		<li>Create a region of interest (ROI) at the wound site and measure the average flux (photons/second) detected. Note that data can also be reported as radiance (photons/second/cm&#178;/steradian), but as long as the distance of the imaging platform from the camera remains constant between imaging, flux is sufficient.</li>
		<li>Measure background by creating a ROI at a random area on the imaging platform. Subtract the background number of photons/second.</li>
		<li>Export the data to a spreadsheet for further analysis.</li>
	</ol>
	</li>
	<li>Perform imaging as described above as often as daily to track infection progression.</li>
</ol>
7. Postoperative management
<ol>
	<li>Monitor mice according to guidelines set by the researcher&#39;s IACUC protocol. We monitor all mice daily for the first 4 days, then every other day until the end of the experiment. Weigh the mice once per day for the first 4 days post-surgery in a BSC. Inject 250 &#181;L of 0.9% sodium chloride subcutaneously on post-infection days 1 and 2.</li>
	<li>Check for signs of pain/distress in the mice, including hunched posture, scruffy coat, lethargy, difficulty breathing, facial grimace, and weight loss.</li>
	<li>If animals display signs of deteriorating health, consult with a veterinarian. Any mouse that appears to show worsening signs of pain/distress and a weight loss of 20% or greater should be euthanized.</li>
</ol>
8. Wound excision
<ol>
	<li>At the end of the experiment, sacrifice the mice using CO2 inhalation, followed by cervical dislocation. Dispose of the animal carcass according to the institution&#39;s ABSL-2 protocols.</li>
	<li>Excise wound beds using sterile scissors and forceps in a BSC. Place each wound bed in 1 mL sterile PBS in a 1.5 mL polypropylene tube. Mince the wound tissue with scissors. All wounds should be treated as ASBL-2, even if they are not considered infected.</li>
	<li>Incubate on a shaker at 300 rpm for 2 h at 4 &#176;C. Vortex each tube for 10 s and serially dilute the bacterial effluent in PBS. Plate the diluted bacterial effluent on LB agar to enumerate the bacterial burden.</li>
	<li>Consider wounds infected if luminescent signal in the wound is above background luminescence and more bacteria are detected in the wound effluent than in wounds inoculated with PBS as control.</li>
</ol>

<ol><li>Sen, C. K., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+skin+wounds%3A+a+major+and+snowballing+threat+to+public+health+and+the+economy%5BTitle%5D)+AND+%22Wound+Repair+and+Regeneration%22%5BJournal%5D)">Human skin wounds: a major and snowballing threat to public health and the economy.</a> Wound Repair and Regeneration. 17 (6), 763-771 (2009).</li>
<li>Serra, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chronic+wound+infections%3A+the+role+of+Pseudomonas+aeruginosa+and+Staphylococcus+aureus%5BTitle%5D)+AND+%22Expert+Review+of+Anti-infective+Therapy%22%5BJournal%5D)">Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus.</a> Expert Review of Anti-infective Therapy. 13 (5), 605-613 (2015).</li>
<li>Obritsch, M. D., Fish, D. N., MacLaren, R., Jung, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Nosocomial+infections+due+to+multidrug-resistant+Pseudomonas+aeruginosa%3A+epidemiology+and+treatment+options%5BTitle%5D)+AND+%22Pharmacotherapy%22%5BJournal%5D)">Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.</a> Pharmacotherapy. 25 (10), 1353-1364 (2005).</li>
<li>Secor, P. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Filamentous+Bacteriophage+Produced+by+Pseudomonas+aeruginosa+Alters+the+Inflammatory+Response+and+Promotes+Noninvasive+Infection+In+Vivo%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo.</a> Infection and Immunity. 85 (1), (2017).</li>
<li>Rice, S. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+biofilm+life+cycle+and+virulence+of+Pseudomonas+aeruginosa+are+dependent+on+a+filamentous+prophage%5BTitle%5D)+AND+%22The+ISME+Journal%22%5BJournal%5D)">The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage.</a> The ISME Journal. 3 (3), 271-282 (2009).</li>
<li>Bayes, H. K., Ritchie, N., Irvine, S., Evans, T. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+murine+model+of+early+Pseudomonas+aeruginosa+lung+disease+with+transition+to+chronic+infection%5BTitle%5D)+AND+%22Scientific+Reports%22%5BJournal%5D)">A murine model of early Pseudomonas aeruginosa lung disease with transition to chronic infection.</a> Scientific Reports. 6, 35838(2016).</li>
<li>van Gennip, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Interactions+between+polymorphonuclear+leukocytes+and+Pseudomonas+aeruginosa+biofilms+on+silicone+implants+in+vivo%5BTitle%5D)+AND+%22Infection+and+Immunity%22%5BJournal%5D)">Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo.</a> Infection and Immunity. 80 (8), 2601-2607 (2012).</li>
<li>Trøstrup, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pseudomonas+aeruginosa+biofilm+aggravates+skin+inflammatory+response+in+BALB%2Fc+mice+in+a+novel+chronic+wound+model%5BTitle%5D)+AND+%22Wound+Repair+and+Regeneration%22%5BJournal%5D)">Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB/c mice in a novel chronic wound model.</a> Wound Repair and Regeneration. 21 (2), 292-299 (2013).</li>
<li>Zhao, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Time+course+study+of+delayed+wound+healing+in+a+biofilm-challenged+diabetic+mouse+model%5BTitle%5D)+AND+%22Wound+Repair+and+Regeneration%22%5BJournal%5D)">Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model.</a> Wound Repair and Regeneration. 20 (3), 342-352 (2012).</li>
<li>Brubaker, A. L., Rendon, J. L., Ramirez, L., Choudhry, M. A., Kovacs, E. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Reduced+neutrophil+chemotaxis+and+infiltration+contributes+to+delayed+resolution+of+cutaneous+wound+infection+with+advanced+age%5BTitle%5D)+AND+%22Journal+of+Immunolology%22%5BJournal%5D)">Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age.</a> Journal of Immunolology. 190 (4), 1746-1757 (2013).</li>
<li>Watters, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Pseudomonas+aeruginosa+biofilms+perturb+wound+resolution+and+antibiotic+tolerance+in+diabetic+mice%5BTitle%5D)+AND+%22Medical+Microbiology+and+Immunology%22%5BJournal%5D)">Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.</a> Medical Microbiology and Immunology. 202 (2), 131-141 (2013).</li>
<li>Lee, C., Kerrigan, C. L., Picard-Ami, L. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Cyclophosphamide-induced+neutropenia%3A+effect+on+postischemic+skin-flap+survival%5BTitle%5D)+AND+%22Plastic+and+Reconstructive+Surgery%22%5BJournal%5D)">Cyclophosphamide-induced neutropenia: effect on postischemic skin-flap survival.</a> Plastic and Reconstructive Surgery. 89 (6), 1092-1097 (1992).</li>
<li>Sweere, J. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+immune+response+to+Chronic+Pseudomonas+aeruginosa+wound+infection+in+immunocompetent+mice%5BTitle%5D)+AND+%22Advances+in+Wound+Care%22%5BJournal%5D)">The immune response to Chronic Pseudomonas aeruginosa wound infection in immunocompetent mice.</a> Advances in Wound Care. , (2019).</li>
<li>Sweere, J. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Bacteriophage+trigger+antiviral+immunity+and+prevent+clearance+of+bacterial+infection%5BTitle%5D)+AND+%22Science%22%5BJournal%5D)">Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection.</a> Science. 363 (6434), (2019).</li>
</ol>

The authors have no competing financial interests to disclose.

We have developed a novel delayed inoculation P. aeruginosa wound infection model. The strategy of delaying inoculation with bacteria until 24 h after excisional wounding enables the evaluation of wound infections over a 1-week timeframe. By using a luminescent strain of P. aeruginosa, it is possible to track infection progression throughout the infection course. The longer course of infection compared to other P. aeruginosa infection models will allow new opportunities for studying host-pathog...

Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative rod-shaped bacterium with increasing relevance to human health and disease. It is responsible for extensive morbidity and mortality in nosocomial settings, particularly involving wound infections in immunocompromised patients1,2. The emergence of multidrug-resistant strains of this pathogen has provided further impetus for investigation into factors contributing to P. aeruginosa virulence, mechanisms of P. aeruginosa antibiotic resistance, and new methods for prevention and treatment of this deadly infection3. As such, the need for animal models of chronic wound infection as tools for investigating these research questions has never been greater.
Unfortunately, many animal models of P. aeruginosa infection tend to simulate acute infection with rapid resolution of infection or rapid decline due to sepsis4,5, which does not adequately simulate the oftentimes chronic nature of these infections. To address this drawback, some models utilize the implantation of foreign bodies such as agar beads, silicone implants, or alginate gels6,7,8. Other models use mice that are immunocompromised due to advanced age, obesity, or diabetes, or through pharmacological means such as cyclophosphamide-induced neutropenia9,10,11,12. However, either the use of foreign materials or immune compromised hosts likely alters the local inflammatory process, making it difficult to gain an understanding of the pathophysiology involved in chronic wound infections in hosts with otherwise normal immune systems.
We have developed a chronic model of P. aeruginosa wound infection in mice that involves delayed inoculation with bacteria after excisional wounding. Delayed inoculation allows for experiments assessing bacterial burden extending out to at least 7 days. This model opens up new opportunities for investigating both pathogenesis and new treatments of P. aeruginosa chronic infections.

<table><tbody><tr><td>0.9% Sodium Chloride injection</td><td>Hospira</td><td>2484457</td><td></td></tr><tr><td>18 G x 1 sterile needle</td><td>BD</td><td>305195</td><td></td></tr><tr><td>25 G x 1 1/5 sterile needle</td><td>BD</td><td>305127</td><td></td></tr><tr><td>Alcohol swab</td><td>BD</td><td>326895</td><td></td></tr><tr><td>Aura Imaging Software</td><td>Spectral Instruments Imaging</td><td>n/a</td><td></td></tr><tr><td>Betadine</td><td>Purdue Frederick Company</td><td>19-065534</td><td></td></tr><tr><td>Buprenorphine SR LAB</td><td>Zoopharm</td><td>n/a</td><td></td></tr><tr><td>C57BL/6J male mice</td><td>The Jackson Laboratory</td><td>000664</td><td></td></tr><tr><td>Disposable biopsy punch, 6mm</td><td>Integra</td><td>33-36</td><td></td></tr><tr><td>Fine scissors - Tungsten Carbide</td><td>Fine Science Tools</td><td>14568-09</td><td></td></tr><tr><td>Glass Bead Dry Sterilizer</td><td>Harvard Apparatus</td><td>61-0183</td><td></td></tr><tr><td>Granulated Agar</td><td>Fisher BioReagents</td><td>BP9744</td><td></td></tr><tr><td>Heating Pad</td><td>Milliard</td><td>804879481218</td><td></td></tr><tr><td>Insulin syringe with 28 G needle</td><td>BD</td><td>329461</td><td></td></tr><tr><td>Lago X Imaging System</td><td>Spectral Instruments Imaging</td><td>n/a</td><td></td></tr><tr><td>LB broth</td><td>Fisher BioReagents</td><td>BP1426</td><td></td></tr><tr><td>Leur-Lok 1 mL syringe</td><td>BD</td><td>309628</td><td></td></tr><tr><td>Mini Arco Animal Trimmer</td><td>Wahl Professional</td><td>919152</td><td></td></tr><tr><td>Nair Hair Removal Lotion with Baby Oil</td><td>Church and Dwight</td><td>n/a</td><td>Available at any pharmacy</td></tr><tr><td>Octagon Forceps</td><td>Fine Science Tools</td><td>11041-08</td><td></td></tr><tr><td>Petri dish</td><td>Falcon</td><td>351029</td><td></td></tr><tr><td>Phosphate Buffered Saline (PBS) 1x</td><td>Corning</td><td>21-040-CV</td><td></td></tr><tr><td>Press and Seal Cling Wrap</td><td>Glad</td><td>n/a</td><td></td></tr><tr><td>SafetyGlide Insulin syringe with 30 G needle</td><td>BD</td><td>305934</td><td></td></tr><tr><td>Safetyglide Insulin syringe, 1/2 mL, 30 G x 5/16 TW</td><td>BD</td><td>305934</td><td></td></tr><tr><td>Scale</td><td>Ohaus Scout Pro</td><td>SP202</td><td></td></tr><tr><td>Supplical Nutritional Supplement</td><td>Henry Schein Animal Health</td><td>29908</td><td></td></tr><tr><td>Tegaderm, 6 cm x 7 cm</td><td>3M</td><td>1624W</td><td></td></tr></tbody></table>

a delayed inoculation model of chronic pseudomonas aeruginosa wound infection

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of chronic wound infections in diabetic and hospitalized patients. There is an urgent need for chronic infection models to aid in the investigation of wound pathogenesis and the development of new therapies against this pathogen. Here, we describe a protocol that uses delayed inoculation 24 hours after full-thickness excisional wounding. The infection of the provisional wound matrix present at this time forestalls either rapid clearance or dissemination of infection and instead establishes chronic infection lasting 7&#8211;10 days without the need for implantation of foreign materials or immune suppression. This protocol mimics a typical temporal course of post-operative infection in humans. The use of a luminescent P. aeruginosa strain (PAO1:lux) allows for quantitative daily assessment of bacterial burden for P. aeruginosa wound infections. This novel model may be a useful tool in the investigation of bacterial pathogenesis and the development of new therapies for chronic P. aeruginosa wound infections.

Using a luminescent strain of PAO1 with a plasmid encoding the luxABCDE reporter system (PAO1:lux), we performed excisional wounding on mice, inoculated these wounds with planktonic P. aeruginosa 24 h later, and measured bacterial burden over time (Figure 1 and Figure 2). A representative image obtained using an imaging optical system demonstrates that this model results in detectable luminescence (F...

We describe a delayed inoculation protocol for generating chronic wound infections in immunocompetent mice.

Pseudomonas aeruginosa (P. aeruginosa) is a major nosocomial pathogen of increasing relevance to human health and disease, particularly in the setting of ...

a-delayed-inoculation-model-chronic-pseudomonas-aeruginosa-wound

Research

JoVE Journal

Immunology and Infection

Source: de Vries, C. R., et.al. A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection. J. Vis. Exp. (2020)This video demonstrates the delayed inoculation of luminescent Pseudomonas aeruginosa into a mouse bearing two full-thickness dorsal skin wounds covered by a transparent film dressing. This facilitates biofilm formation and the establishment of chronic infection. Regular bioluminescence monitoring enables quantification of bacterial burden and tracking of infection...

Developing a Mouse Model of Chronic Pseudomonas aeruginosa Skin Wound Infection 

We describe the agar-beads method to establish persistent long-term chronic Pseudomonas aeruginosa airway infection in the mouse model.

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

We have developed a mouse lung injury model by intra-tracheal injection of bacteria Pseudomonas aeruginosa. This model mimics lung injury during pneumonia and is clinically relevant.

Pseudomonas aeruginosa Induced Lung Injury Model

While in vitro study of host-pathogen interactions allow the characterization of specific immune responses, in vivo models are required to observe the effects of complex responses. Using Candida albicans exposure followed by Pseudomonas aeruginosa-mediated lung infection, we established a murine model of microbial interactions involved in ventilator-associated pneumonia pathogenicity.

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Here we describe a novel diabetic murine model utilizing hairless mice for real-time, non-invasive, monitoring of biofilm wound infections of bioluminescent Pseudomonas aeruginosa. This method can be adapted to evaluate infection of other bacterial species and genetically modified microorganisms, including multi-species biofilms, and test the efficacy of antibiofilm strategies.

Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model

Here we describe a protocol that allows histological and molecular analysis of skin samples after Candida albicans intradermal injection. This protocol maintains the structural integrity of the skin and allows for the localization of tissue-resident or newly recruited immune cells as well as the pathogen distribution.

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

There is an update associated with this article. Please click here to see the update. Chronic wounds are developed from acute wounds on a diabetic mouse model by inducing high levels of oxidative stress after a full-thickness cutaneous wound. The wound is treated with inhibitors for catalase and glutathione peroxidase, resulting in impaired healing and biofilm development by bacteria present in the skin microbiome.

Protocol to Create Chronic Wounds in Diabetic Mice

Periprosthetic joint infection (PJI) caused by dangerous pathogens is common in clinical orthopedics. Existing animal models cannot accurately simulate the actual situation of PJI. Here, we established a Candida albicans biofilm-associated PJI mouse model to research and develop new therapeutics for PJI.

A Periprosthetic Joint Candida albicans Infection Model in Mouse

Chronic wounds that are resistant to antibiotics are a major threat to the healthcare system. Biofilm infections are stubborn and hostile and can cause deficient functional wound closure. We report a clinically relevant swine model of biofilm-infected full-thickness chronic wounds. This model is powerful for mechanistic studies as well as for testing interventions.

Swine Model of Biofilm Infection and Invisible Wounds

There is currently a lack of in vivo models amenable to drug screening against chronic bacterial infections. Here, we describe a protocol for wound infection by a Pseudomonas aeruginosa clinical isolate to generate a persistent infection in zebrafish larvae.

Modeling Persistent Pseudomonas aeruginosa Infection in Wounded Zebrafish Larvae

Learn a delayed inoculation protocol for chronic Pseudomonas aeruginosa wound infection in immunocompetent mice without immune suppression. This model enables bacterial pathogenesis and host-pathogen interaction studies.

A Delayed Inoculation Model of Chronic Pseudomonas aeruginosa Wound Infection

Explore More Videos